BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2961250)

  • 1. Population implications of electrocardiographic left ventricular hypertrophy.
    Kannel WB; Dannenberg AL; Levy D
    Am J Cardiol; 1987 Dec; 60(17):85I-93I. PubMed ID: 2961250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and natural history of electrocardiographic left ventricular hypertrophy.
    Kannel WB
    Am J Med; 1983 Sep; 75(3A):4-11. PubMed ID: 6226193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy, arrhythmias and sudden death in systemic hypertension.
    Borhani NO
    Am J Cardiol; 1987 Dec; 60(17):13I-18I. PubMed ID: 2961245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study.
    Levy D; Anderson KM; Savage DD; Balkus SA; Kannel WB; Castelli WP
    Am J Cardiol; 1987 Sep; 60(7):560-5. PubMed ID: 2957907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis after acute myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram. SPRINT Study Group.
    Behar S; Reicher-Reiss H; Abinader E; Agmon J; Barzilai J; Friedman Y; Kaplinsky E; Kauli N; Kishon Y; Palant A
    Am J Cardiol; 1992 Apr; 69(12):985-90. PubMed ID: 1532881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy.
    Aronow WS; Ahn C; Kronzon I; Koenigsberg M
    Am J Cardiol; 1991 Feb; 67(4):295-9. PubMed ID: 1825011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study.
    Kannel WB; Levy D; Cupples LA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of electrocardiographic criteria for left and right ventricular hypertrophy in morbid obesity.
    Nath A; Alpert MA; Terry BE; Kelly DL
    Am J Cardiol; 1988 Jul; 62(1):126-30. PubMed ID: 2968039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension, hypertrophy, and the occurrence of cardiovascular disease.
    Kannel WB
    Am J Med Sci; 1991 Oct; 302(4):199-204. PubMed ID: 1833977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of cardiac risk in hypertensive patients with left heart hypertrophy].
    Schulte KL; Meyer-Sabellek W; Liederwald K; Eisenhut C; Distler A; Gotzen R
    Z Kardiol; 1991; 80 Suppl 1():37-40. PubMed ID: 1827230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy. Significance in cardiac morbidity and mortality.
    Aronow WS
    Postgrad Med; 1990 Mar; 87(4):147-50, 155-8. PubMed ID: 2138288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy, arterial hypertension and sudden death.
    Messerli FH
    J Hypertens Suppl; 1990 Dec; 8(7):S181-6. PubMed ID: 2151334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
    Kannel WB
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy and myocardial ischemia in systemic hypertension.
    Dunn FG; Pringle SD
    Am J Cardiol; 1987 Dec; 60(17):19I-22I. PubMed ID: 2961246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study.
    Kannel WB; Abbott RD
    Am Heart J; 1986 Feb; 111(2):391-7. PubMed ID: 2936230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.
    Maron BJ; Wolfson JK; CirĂ³ E; Spirito P
    Am J Cardiol; 1983 Jan; 51(1):189-94. PubMed ID: 6217739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy.
    Messerli FH; Ventura HO; Elizardi DJ; Dunn FG; Frohlich ED
    Am J Med; 1984 Jul; 77(1):18-22. PubMed ID: 6234799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy: its prime importance as a controllable risk factor.
    Weber JR
    Am Heart J; 1988 Jul; 116(1 Pt 2):272-9. PubMed ID: 2969187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis.
    Kuller LH; Hulley SB; Cohen JD; Neaton J
    Circulation; 1986 Jan; 73(1):114-23. PubMed ID: 2416486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.